Sunflower Therapeutics is a biotech company that delivers next-generation protein manufacturing solutions.
Sunflower Therapeutics has raised $300K in total funding. The most recent round was Grant. The last funding was announced in September 2025.
Sunflower Therapeutics's investors include Bill & Melinda Gates Foundation, SK Bioscience, National Institute of Allergy and Infectious Diseases, Emerald Development Managers.
Sunflower Therapeutics is headquartered in Hingham, United States.
Sunflower Therapeutics is a biotech company that delivers next-generation protein manufacturing solutions.
Sunflower Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sunflower Therapeutics — Funding & Investors." VCBacked, September 3, 2025, https://www.vcbacked.co/company/sunflower-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). Sunflower Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/sunflower-therapeutics
{{cite web |title=Sunflower Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sunflower-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated